# Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality

> **NCT00668707** · PHASE3 · COMPLETED · sponsor: **The Canadian College of Naturopathic Medicine** · enrollment: 709 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** melatonin
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT00668707
- **Lead sponsor:** The Canadian College of Naturopathic Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2017-03-09
- **Final completion:** 2017-11-30
- **Target enrollment:** 709 (ACTUAL)
- **Last updated:** 2021-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668707, "Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00668707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*